EKSPERIMENTAL ALLOKSAN DIABETDA GLYUKOZA MIQDORI VA LIPID MIQDORIGA ANTIOKSIDANT MODDALARNING TA’SIRI.
Mardonov S. Y.
Annotatsiya
Antioksidant ta'sirining turli mexanizmlariga ega bo'lgan moddalarning uglevodlar va lipidlar almashinuvi parametrlariga, antioksidant tizimning tiol komponentiga va funksional detoksifikatsiya tizimiga ta’siri dekompensatsiyalangan alloksan qandli diabetni modellashtirishda o‘rganildi. Tadqiqot boshlang‘ich tana og‘irligi 180-200 g bo‘lgan 60 ta oq erkak kalamushlarda o‘tkazildi. Qandli diabetning rivojlanishi kalamushlarda qon plazmasidagi glyukoza konsentratsiyasining 6,9 baravar, umumiy xolesterin va past zichlikdagi lipoproteinlar mos ravishda 66 va 100% ga oshishi bilan birga kuzatiladi. Antiradikal himoya fermentlari (glutation peroksidaza va glutationreduktaza) faolligining oshishi va eritrotsitlarda kamaygan glutation konsentratsiyasining 11% ga pasayishi kuzatiladi.
Adabiyotlar
- American Diabetes Association. (2023). Classification and diagnosis of diabetes: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S19–S40. https://doi.org/10.2337/dc23-S002
- Baynes, J. W., & Thorpe, S. R. (1999). Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes, 48(1), 1–9. https://doi.org/10.2337/diabetes.48.1.1
- Ceriello, A., & Motz, E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology, 24(5), 816–823. https://doi.org/10.1161/01.ATV.0000122852.22604.78
- Desco, M. C., Asensi, M., Márquez, R., Martínez-Valls, J., Vento, M., Pallardó, F. V., & Viña, J. (2002). Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes, 51(4), 1118–1124. https://doi.org/10.2337/diabetes.51.4.1118
- Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
- Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51(2), 216–226. https://doi.org/10.1007/s00125-007-0886-7
- Palsamy, P., & Subramanian, S. (2008). Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling. Biochimica et Biophysica Acta, 1782(5), 425–435. https://doi.org/10.1016/j.bbadis.2008.03.008
- Reed, L. J. (1974). Multienzyme complexes. Accounts of Chemical Research, 7(2), 40–46. https://doi.org/10.1021/ar50074a001
- Stacpoole, P. W. (2017). The pharmacology of dichloroacetate. Metabolism, 65(2), 229–238. https://doi.org/10.1016/j.metabol.2015.12.005
- Tang, S. M., Deng, X. T., Zhou, J., Li, Q. P., Ge, X. X., & Miao, L. (2019). Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomedicine & Pharmacotherapy, 121, 109604. https://doi.org/10.1016/j.biopha.2019.109604